Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations
- 14 August 2001
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 65 (2), 218-224
- https://doi.org/10.1002/jmv.2023
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and SelectionJournal of Virology, 2000
- Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapyAIDS, 1999
- The Dynamics of Human Cytomegalovirus Replication in VivoThe Journal of Experimental Medicine, 1999
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Altered Drug Sensitivity, Fitness, and Evolution of Human Immunodeficiency Virus Type 1 withpolGene Mutations Conferring Multi‐Dideoxynucleoside ResistanceThe Journal of Infectious Diseases, 1998
- British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1997
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencingNature, 1993
- Introduction to Theoretical Population GeneticsPublished by Springer Nature ,1992